Transparency

As a result of collaboration between the pharmaceutical industry and healthcare professionals, several innovative medicines have been born and the impact of various diseases on our lives has diminished. At Bayer, we believe that better collaboration with healthcare professionals and continuous training of experts will lead to better results in patient care.

In working with healthcare professionals, we comply with applicable laws, regulations and industry codes that clearly govern the relationship between the industry and healthcare professionals. These rules are amended by additional transparency regulations, such as the U.S. Sunshine Act, the European EFPIA Transparency Code, and various local reporting obligations. We fully respect the independence and integrity of our professionals.

As a member of the European Federation of Pharmaceutical Industries and Associations (EFPIA), Bayer is committed to ensure industry transparency and recognize the rules of the EFPIA Transparency Code as binding on itself.

Under the EFPIA Transparency Code, Bayer also publishes cash and non-cash benefits to healthcare professionals and organizations on its global and local websites.

In order to make the nature and extent of contact between the pharmaceutical industry and healthcare professionals and organizations more transparent, all benefits provided in connection with the products are documented and disclosed in the framework of the AIPM Transparency Code. In working with healthcare professionals, we comply with applicable laws and regulations, various local reporting obligations, and fully respect the independence and integrity of professionals.

Download PDF